Suven Life Sciences net profit declined 11.5 per cent at ₹32.2 crore in the third quarter ended December 31, 2014, against ₹36 crore in the corresponding quarter of previous year. Total income, however, increased 9 per cent at ₹131 crore (₹120 crore). The reduction in profit was due to charge of additional depreciation computed as per the Companies Act 2013 effective April 1, 2014, shown as exceptional item in the profit & loss account.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.